Skip to main content
Heather  Bax

Dr Heather Bax

Postdoctoral Research Fellow

Research interests

  • Cancer
  • Biomedical and life sciences

Contact details

Biography

Developing novel antibodies of the IgE class to target solid tumours. Supporting the first-in-class, first-in-man, Phase 1 clinical trial of MOv18 IgE (ClinicalTrials.gov Identifier: NCT02546921). Now funded by IGEM Therapeutics Ltd (www.igemtherapeutics.com). Research programs include pre-clinical development of IgE antibodies against ovarian, breast (including TNBC), melanoma and lung cancers.

    Research

    tubes 1800 x 500 banner.
    Cancer Antibody Discovery & Immunotherapy Group

    The Cancer Antibody Discovery & Immunotherapy Group is led by Professor Sophia Karagiannis

    News

    Study shows promising results for immunotherapy targeting skin cancer

    A new class of immunotherapy shows promising results for fighting the most aggressive form of skin cancer.

    Cancer cells

      Research

      tubes 1800 x 500 banner.
      Cancer Antibody Discovery & Immunotherapy Group

      The Cancer Antibody Discovery & Immunotherapy Group is led by Professor Sophia Karagiannis

      News

      Study shows promising results for immunotherapy targeting skin cancer

      A new class of immunotherapy shows promising results for fighting the most aggressive form of skin cancer.

      Cancer cells